92 related articles for article (PubMed ID: 16691537)
1. MUC1 cytoplasmic tail detection using CT33 polyclonal and CT2 monoclonal antibodies in breast and colorectal tissue.
Croce MV; Isla-Larrain M; Remes-Lenicov F; Colussi AG; Lacunza E; Kim KC; Gendler SJ; Segal-Eiras A
Histol Histopathol; 2006 Aug; 21(8):849-55. PubMed ID: 16691537
[TBL] [Abstract][Full Text] [Related]
2. Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer.
Croce MV; Isla-Larrain MT; Rua CE; Rabassa ME; Gendler SJ; Segal-Eiras A
J Histochem Cytochem; 2003 Jun; 51(6):781-8. PubMed ID: 12754289
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical study of MUC1 and carbohydrate antigens in breast benign disease and normal mammary gland.
Demichelis SO; Alberdi CG; Servi WJ; Isla-Larrain MT; Segal-Eiras A; Croce MV
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):41-50. PubMed ID: 19625949
[TBL] [Abstract][Full Text] [Related]
4. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
[TBL] [Abstract][Full Text] [Related]
5. Tissue and serum MUC1 mucin detection in breast cancer patients.
Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1-acid glycoprotein (AGP): a possible carrier of sialyl lewis X (slewis X) antigen in colorectal carcinoma.
Croce MV; Sálice VC; Lacunza E; Segal-Eiras A
Histol Histopathol; 2005 Jan; 20(1):91-7. PubMed ID: 15578427
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localization of MUC1 extracellular domain in breast, head and neck, and colon cancer.
Rabassa ME; Larrain MT; Lacunza E; Cermignani L; Alberdi CG; Demichelis SO; Abba MC; Segal-Eiras A; Croce MV
Int J Biol Markers; 2015 Jul; 30(3):e294-300. PubMed ID: 25982681
[TBL] [Abstract][Full Text] [Related]
9. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating anti-MUC1 mucin core protein antibodies in patients with colorectal cancer.
Nakamura H; Hinoda Y; Nakagawa N; Makiguchi Y; Itoh F; Endo T; Imai K
J Gastroenterol; 1998 Jun; 33(3):354-61. PubMed ID: 9658314
[TBL] [Abstract][Full Text] [Related]
11. Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation.
Cao Y; Blohm D; Ghadimi BM; Stosiek P; Xing PX; Karsten U
J Histochem Cytochem; 1997 Nov; 45(11):1547-57. PubMed ID: 9358856
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients.
Isla Larrain MT; Colussi AG; Demichelis SO; Barbera A; Cretón A; Segal-Eiras A; Croce MV
Int J Biol Markers; 2013 Sep; 28(3):318-25. PubMed ID: 23828406
[TBL] [Abstract][Full Text] [Related]
13. Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8.
Dian D; Lenhard M; Mayr D; Heublein S; Karsten U; Goletz S; Kuhn C; Wiest I; Friese K; Weissenbacher T; Jeschke U
Histol Histopathol; 2013 Feb; 28(2):239-44. PubMed ID: 23275306
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.
Heublein S; Mayr D; Egger M; Karsten U; Goletz S; Angele M; Gallwas J; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2015 May; 34(1):50. PubMed ID: 25986064
[TBL] [Abstract][Full Text] [Related]
15. Expression of monoclonal-antibody-defined antigens in fractions isolated from human breast carcinomas and patients' serum.
Croce MV; Price MR; Segal-Eiras A
Cancer Immunol Immunother; 1995 Feb; 40(2):132-7. PubMed ID: 7882384
[TBL] [Abstract][Full Text] [Related]
16. MUC1 serum assays in breast cancer: tumor specificities and reference levels.
Bjerner J; Norum LF; Nilsson O; Nustad K
Tumour Biol; 2002; 23(6):315-23. PubMed ID: 12677089
[TBL] [Abstract][Full Text] [Related]
17. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
18. Intra-colonic administration of a polymer-bound NIRF probe for improved colorectal cancer detection during colonoscopy.
Kogan-Zviagin I; Shamay Y; Nissan A; Sella-Tavor O; Golan M; David A
J Control Release; 2014 Oct; 192():182-91. PubMed ID: 25008468
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evidence of Muc1 expression during rat embryonic development.
Lacunza E; Ferretti V; Barbeito C; Segal-Eiras A; Croce MV
Eur J Histochem; 2010 Nov; 54(4):e49. PubMed ID: 21263748
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
Grinstead JS; Schuman JT; Campbell AP
Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
